Supplements
5-Amino-1MQ Capsules 50mg (60 Count)
Overview
This product scores low overall due to absence of human clinical evidence despite promising mouse studies (e.g., PMC5826726: 5-amino-1MQ at ~34 mg/kg/day SC reduced obesity markers without toxicity). Effectiveness is preclinical-only (15/100), as no RCTs or human trials confirm fat loss or metabolic claims at 50mg oral dose, which lacks established human equivalence. Safety (50/100) reflects no major preclinical issues but critical gaps in human pharmacokinetics, dosing safety, and interactions.
Key strengths
- Promising preclinical mechanism for fat loss via NNMT inhibition without appetite suppression
- No observed toxicity in short-term mouse studies
- Anecdotal reports of increased energy and metabolism
Our analysis
Avoid 5-Amino-1MQ capsules due to lack of human clinical evidence and safety data; preclinical promise unvalidated in people. Opt for proven weight management options under medical supervision. Monitor for future trials before considering.
Frequently asked questions
- Is 5-Amino-1MQ Capsules 50mg (60 Count) worth buying?
- 5-Amino-1MQ Capsules 50mg (60 Count) has a Verify Influencers trust score of 34/100 based on ingredient quality, clinical evidence, and third-party testing.
- What is the trust score for 5-Amino-1MQ Capsules 50mg (60 Count)?
- 5-Amino-1MQ Capsules 50mg (60 Count) scored 34 out of 100 in our science-backed analysis, which evaluates ingredient dosages against clinical literature and manufacturing transparency.
Browse all scored products · How products are scored